JPMORGAN CHASE & CO - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 74 filers reported holding LUX HEALTH TECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q2 2022$15,000
-99.4%
1,500
-99.4%
0.00%
Q1 2022$2,480,000
+16433.3%
251,500
+16666.7%
0.00%
Q4 2021$15,000
-99.4%
1,500
-99.4%
0.00%
Q3 2021$2,453,000
-0.8%
250,0000.0%0.00%
Q2 2021$2,473,000250,0000.00%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q3 2022
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 1,700,000$16,813,00084.84%
MYDA Advisors LLC 900,000$8,901,0002.49%
Empyrean Capital Partners, LP 3,000,649$29,676,0000.94%
Tuttle Capital Management, LLC 30,166$298,0000.83%
Silver Rock Financial LP 369,442$3,654,0000.80%
BBR PARTNERS, LLC 639,999$6,330,0000.74%
Governors Lane LP 725,000$7,170,0000.57%
Mint Tower Capital Management B.V. 606,757$6,001,0000.48%
Spartan Fund Management Inc. 226,753$2,243,0000.48%
Privium Fund Management (UK) Ltd 40,353$399,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders